{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:23:35Z","timestamp":1740140615837,"version":"3.37.3"},"reference-count":36,"publisher":"Walter de Gruyter GmbH","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>POEMS syndrome is defined by Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy and Skin changes. The vascular endothelial growth factor (VEGF) appears to play a key role in the pathogenesis of the syndrome, and its concentrations are deemed to correlate to disease activity. The aim of the present study was to verify whether other biochemical markers including serum free light chains (FLC) and heavy\/light chains (HLC) would be of value in monitoring POEMS patients.<\/jats:p><jats:p>Fifty-three serum samples were collected from seven POEMS patients at diagnosis and during a follow-up period (range 14\u201356 months). VEGF was measured using an ELISA method, while FLC and HLC concentrations were measured using Binding Site reagents on a BNII (Siemens) nephelometer.<\/jats:p><jats:p>At diagnosis all patients presented high VEGF concentrations, while the \u03ba\/\u03bbFLC ratio (FLCr) was within the reference range. Four patients had abnormal HLC, HLC\u03ba\/HLC\u03bb (HLCr) and FLC values. The relationship between the trend of VEGF and both HLC and FLC during the follow-up was analysed by means of Cohen\u2019s \u03ba coefficient. VEGF and HLC values displayed a significant \u03ba-Cohen (0.537, p=0.002) in all chemotherapy-responder patients while in non-responders it did not. Conversely, in both responders and non-responders, VEGF and FLC values did not attain a significance on \u03ba-Cohen analysis. In three out of four responders HLCr values increased, thus reflecting an improved clinical condition.<\/jats:p><jats:p>The findings made in the present study indicate that HLC, either as intact immunoglobulin or as HLCr, may provide useful information, particularly in identifying responders and confirm that the role of FLC is unreliable in monitoring patients with POEMS syndrome.<\/jats:p>","DOI":"10.1515\/cclm-2015-0910","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T17:01:36Z","timestamp":1460480496000},"source":"Crossref","is-referenced-by-count":2,"title":["Free light chains and heavy\/light chains in monitoring POEMS patients"],"prefix":"10.1515","volume":"54","author":[{"given":"Sara","family":"Altinier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozeta","family":"Proko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Zaninotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Ciubotaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Seguso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariacristina","family":"Varagnolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Lessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Briani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Adami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0270-1711","authenticated-orcid":false,"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref101","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1373\/clinchem.2014.231985","article-title":"Monitoring IgA multiple myeloma: immunoglobulin heavy\/light chain assays","volume":"61","year":"2015","journal-title":"Clin Chem"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/leu.2012.197","article-title":"Immunoglobulin heavy\/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients","volume":"27","year":"2013","journal-title":"Leukemia"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.clinbiochem.2013.01.014","article-title":"Serum free light chain reference values: a critical approach","volume":"46","year":"2013","journal-title":"Clin Biochem"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2012-04-423178","article-title":"Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience","volume":"120","year":"2012","journal-title":"Blood"},{"key":"ref191","first-page":"214","article-title":"POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management","volume":"89","year":"2014","journal-title":"Am J Hematol"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2012-04-423178","article-title":"Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience","volume":"120","year":"2012","journal-title":"Blood"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.clinbiochem.2013.01.014","article-title":"Serum free light chain reference values: a critical approach","volume":"46","year":"2013","journal-title":"Clin Biochem"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1002\/cncr.28946","article-title":"IgA kappa\/IgA lambda heavy\/light chain assessment in the management of patients with IgA myeloma","volume":"120","year":"2014","journal-title":"Cancer"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00277-014-2019-y","article-title":"Serum immunoglobulin free light chain and heavy\/light chain measurements in POEMS syndrome","volume":"93","year":"2014","journal-title":"Ann Hematol"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","year":"2003","journal-title":"Blood"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","year":"2005","journal-title":"Brain"},{"key":"ref271","first-page":"1","article-title":"Ratio of involved\/uninvolved immunoglobulin quantification by Hevylite\u2122 assay: clinical and prognostic impact in multiple myeloma","volume":"23","year":"2012","journal-title":"Exp Hematol Oncol"},{"journal-title":"Eur J Haematol","article-title":"Prognostic value of serum heavy\/light chain ratios in patients with POEMS syndrome","year":"2015","key":"ref351"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ajh.21707","article-title":"Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome","volume":"85","year":"2010","journal-title":"Am J Hematol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","year":"2011","journal-title":"Blood"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/leu.2012.197","article-title":"Immunoglobulin heavy\/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients","volume":"27","year":"2013","journal-title":"Leukemia"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2009.123828","article-title":"Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin \u03ba\/\u03bb ratios","volume":"55","year":"2009","journal-title":"Clin Chem"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","year":"2003","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/art.1780400430","article-title":"Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor","volume":"40","year":"1997","journal-title":"Arthritis Rheum"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","year":"2001","journal-title":"Clin Chem"},{"journal-title":"Eur J Haematol","article-title":"Prognostic value of serum heavy\/light chain ratios in patients with POEMS syndrome","year":"2015","key":"ref171"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","year":"2011","journal-title":"Blood"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/leu.2012.189","article-title":"Suppression of uninvolved immunoglobulins defined by heavy\/light chain pair suppression is a risk factor for progression of MGUS","volume":"27","year":"2013","journal-title":"Leukemia"},{"key":"ref11","first-page":"214","article-title":"POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management","volume":"89","year":"2014","journal-title":"Am J Hematol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","year":"2001","journal-title":"Clin Chem"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1002\/cncr.28946","article-title":"IgA kappa\/IgA lambda heavy\/light chain assessment in the management of patients with IgA myeloma","volume":"120","year":"2014","journal-title":"Cancer"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2009.123828","article-title":"Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin \u03ba\/\u03bb ratios","volume":"55","year":"2009","journal-title":"Clin Chem"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/art.1780400430","article-title":"Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor","volume":"40","year":"1997","journal-title":"Arthritis Rheum"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1373\/clinchem.2014.231985","article-title":"Monitoring IgA multiple myeloma: immunoglobulin heavy\/light chain assays","volume":"61","year":"2015","journal-title":"Clin Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","year":"2005","journal-title":"Brain"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","year":"2009","journal-title":"Leukemia"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/leu.2012.189","article-title":"Suppression of uninvolved immunoglobulins defined by heavy\/light chain pair suppression is a risk factor for progression of MGUS","volume":"27","year":"2013","journal-title":"Leukemia"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","year":"2009","journal-title":"Leukemia"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00277-014-2019-y","article-title":"Serum immunoglobulin free light chain and heavy\/light chain measurements in POEMS syndrome","volume":"93","year":"2014","journal-title":"Ann Hematol"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ajh.21707","article-title":"Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome","volume":"85","year":"2010","journal-title":"Am J Hematol"},{"key":"ref91","first-page":"1","article-title":"Ratio of involved\/uninvolved immunoglobulin quantification by Hevylite\u2122 assay: clinical and prognostic impact in multiple myeloma","volume":"23","year":"2012","journal-title":"Exp Hematol Oncol"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0910\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T17:33:11Z","timestamp":1718472791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0910\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":36,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1515\/cclm-2015-0910","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"type":"electronic","value":"1437-4331"},{"type":"print","value":"1434-6621"}],"subject":[],"published":{"date-parts":[[2016,1,1]]}}}